Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Longeveron Inc LGVN

Longeveron Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy... see more

NDAQ:LGVN - Post Discussion

Longeveron Inc > New Study Shows Social Isolation, Frailty Worsen Health Risk
View:
Post by whytestocks on Apr 17, 2024 6:00pm

New Study Shows Social Isolation, Frailty Worsen Health Risk

Just In: $LGVN New Study Shows Social Isolation, Frailty Worsen Health Risks for Aging PeopleA recently published review has found that social vulnerability and frailty worsen as individuals age. When both are present, these conditions result in a considerably heightened decline in cognitive and physical function as well as mortality risk. So, what is frailty? Theoretically, frai...LGVN - New Study Shows Social Isolation, Frailty Worsen Health Risks for Aging People
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities